Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
38.95%
↑ 100% above average
Average (29q)
-2562287.04%
Historical baseline
Range
High:9010.68%
Low:-55583810.00%
Volatility
-2169.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 38.95% |
| Q2 2025 | 4.04% |
| Q1 2025 | -124.21% |
| Q4 2024 | 9010.68% |
| Q3 2024 | 43.19% |
| Q2 2024 | 4.27% |
| Q1 2024 | 23.27% |
| Q4 2023 | 52.17% |
| Q3 2023 | -64.29% |
| Q2 2023 | 69.57% |
| Q1 2023 | -130.00% |
| Q4 2022 | 31.03% |
| Q3 2022 | 39.58% |
| Q2 2022 | 100.00% |
| Q1 2022 | -55583810.00% |
| Q4 2021 | -3.45% |
| Q3 2021 | -123.08% |
| Q2 2021 | -36.27% |
| Q1 2021 | 99.97% |
| Q4 2020 | -3391.56% |
| Q3 2020 | -20723873.44% |
| Q2 2020 | -22600.86% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2005 | -1758.33% |
| Q3 2005 | 95.08% |
| Q2 2005 | -542307.41% |
| Q1 2005 | 0.00% |
| Q4 2004 | 0.00% |
| Q3 2004 | 0.00% |